Back

Physiology- versus angiography-guided complete coronary revascularization in STEMI patients with multivessel disease: a network meta-analysis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Optimising revascularisation in acute coronary syndromes ST-Elevation Myocardial Infarction (STEMI) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Giovanni Martino

University of Calabria, Rende (Italy)

5 More presentations in this session

Presentation thumbnail
Intervention therapy versus conservative therapy of non-ST elevation myocardial infarction patients with malnutrition : a multi-center real-world study
Doctor R. Guo (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Bleeding risk and cardiovascular outcomes in acute myocardial infarction patients with multivessel disease: a post-hoc analysis of the Japan AMI registry
Doctor K. Nakamura (Kumamoto, JP)
Abstract Slides Video
Presentation thumbnail
Impact of residual lesions in non-infarct-related coronary arteries on long-term outcomes in STEMI patients undergoing primary PCI
Doctor M. Liu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Revascularization strategies in non-ST-elevation acute coronary syndrome with multivessel disease temporal trends in utilization and associated outcomes
Doctor F. Jokhaji (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Completeness of revascularization in relation to major cardiovascular events in patients with ST-elevation myocardial infarction and multivessel disease: results from the COMPLETE trial
Doctor M. Madanchi (Hamilton, CA)
Abstract Slides Video

Access the full session

Session thumbnail
Optimising revascularisation in acute coronary syndromes
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Optimising revascularisation in acute coronary syndromes
thumbnail
Congress Session
Long-term outcomes and innovations in revascularisation strategies
thumbnail
Congress Session
Late-Breaking Clinical Trials: coronary artery disease and interventions

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources